Ameritas Investment Partners’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Buy |
8,119
+1,254
| +18% | +$31K | 0.01% | 1261 |
|
|
2026
Q1 | $148K | Buy |
6,865
+481
| +8% | +$10.4K | ﹤0.01% | 1441 |
|
|
2025
Q4 | $152K | Buy |
6,384
+625
| +11% | +$12.8K | ﹤0.01% | 1432 |
|
|
2025
Q3 | $78.3K | Sell |
5,759
-1,279
| -18% | -$13.3K | ﹤0.01% | 1842 |
|
|
2025
Q2 | $57.3K | Buy |
7,038
+1,796
| +34% | +$15.3K | ﹤0.01% | 2100 |
|
|
2025
Q1 | $41.1K | Hold |
5,242
| – | – | ﹤0.01% | 2222 |
|
|
2024
Q4 | $78.1K | Hold |
5,242
| – | – | ﹤0.01% | 1928 |
|
|
2024
Q3 | $80.2K | Hold |
5,242
| – | – | ﹤0.01% | 1923 |
|
|
2024
Q2 | $79.8K | Hold |
5,242
| – | – | ﹤0.01% | 1870 |
|
|
2024
Q1 | $99K | Hold |
5,242
| – | – | ﹤0.01% | 1749 |
|
|
2023
Q4 | $100K | Hold |
5,242
| – | – | ﹤0.01% | 1730 |
|
|
2023
Q3 | $94.1K | Buy |
5,242
+886
| +20% | +$17.8K | ﹤0.01% | 1704 |
|
|
2023
Q2 | $88.5K | Buy |
4,356
+459
| +12% | +$8.74K | ﹤0.01% | 1686 |
|
|
2023
Q1 | $71.1K | Hold |
3,897
| – | – | ﹤0.01% | 1761 |
|
|
2022
Q4 | $85.8K | Hold |
3,897
| – | – | ﹤0.01% | 1708 |
|
|
2022
Q3 | $101K | Buy |
3,897
+305
| +8% | +$8.07K | ﹤0.01% | 1482 |
|
|
2022
Q2 | $91K | Hold |
3,592
| – | – | ﹤0.01% | 1583 |
|
|
2022
Q1 | $113K | Hold |
3,592
| – | – | ﹤0.01% | 1562 |
|
|
2021
Q4 | $145K | Hold |
3,592
| – | – | ﹤0.01% | 1450 |
|
|
2021
Q3 | $125K | Hold |
3,592
| – | – | ﹤0.01% | 1554 |
|
|
2021
Q2 | $99K | Hold |
3,592
| – | – | ﹤0.01% | 1727 |
|
|
2021
Q1 | $101K | Hold |
3,592
| – | – | ﹤0.01% | 1666 |
|
|
2020
Q4 | $93K | Hold |
3,592
| – | – | ﹤0.01% | 1625 |
|
|
2020
Q3 | $62K | Buy |
3,592
+760
| +27% | +$17K | ﹤0.01% | 1707 |
|
|
2020
Q2 | $70K | Buy |
2,832
+300
| +12% | +$8.1K | ﹤0.01% | 1628 |
|
|
2020
Q1 | $35K | Hold |
2,532
| – | – | ﹤0.01% | 1862 |
|
|
2019
Q4 | $26K | Hold |
2,532
| – | – | ﹤0.01% | 2282 |
|
|
2019
Q3 | $23K | Hold |
2,532
| – | – | ﹤0.01% | 2319 |
|
|
2019
Q2 | $20K | Hold |
2,532
| – | – | ﹤0.01% | 2444 |
|
|
2019
Q1 | $32K | Hold |
2,532
| – | – | ﹤0.01% | 2119 |
|
|
2018
Q4 | $27K | Buy |
2,532
+2,100
| +486% | +$24.5K | ﹤0.01% | 2163 |
|
|
2018
Q3 | $6K | Hold |
432
| – | – | ﹤0.01% | 2931 |
|
|
2018
Q2 | $5K | Buy |
+432
| New | +$6.78K | ﹤0.01% | 2942 |
|
Other funds holding RCUS
GS
SCM
WP
Ameritas Investment Partners's RCUS Position: Q2 2026 in Review
Ameritas Investment Partners increased its Arcus Biosciences (RCUS) stake by 18% in Q2 2026, buying an estimated $31K and bringing the position to 8,119 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #1261.
Ameritas Investment Partners first reported a position in RCUS in Q2 2018 and has held it in 33 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- Ameritas Investment Partners held 8,119 shares of Arcus Biosciences worth $250K as of Q2 2026.
- Ameritas Investment Partners bought 1,254 Arcus Biosciences shares in Q2 2026, an estimated $31K.
- Arcus Biosciences made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1261 holding.
- Ameritas Investment Partners first reported a position in Arcus Biosciences in Q2 2018 and has held it in 33 quarters since.
- 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.